A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice
Author(s) -
Tianyang Mao,
Benjamin Israelow,
Carolina Lucas,
Chantal B. F. Vogels,
Maria Luisa Gomez-Calvo,
Olga Fedorova,
Mallery I. Breban,
Bridget L. Menasché,
Huiping Dong,
Melissa Linehan,
Tara Alpert,
F. Brito Anderson,
Rebecca Earnest,
Joseph R. Fauver,
Chaney C. Kalinich,
Ketty Munyenyembe,
Isabel M. Ott,
Mary E. Petrone,
Jessica E. Rothman,
Anne E. Watkins,
Craig B. Wilen,
Marie L. Landry,
Nathan D. Grubaugh,
Anna Marie Pyle,
Akiko Iwasaki
Publication year - 2021
Publication title -
the journal of experimental medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.483
H-Index - 448
eISSN - 1540-9538
pISSN - 0022-1007
DOI - 10.1084/jem.20211818
Subject(s) - context (archaeology) , immunology , immune system , interferon , immunity , innate immune system , disease , chronic infection , agonist , medicine , biology , virology , receptor , paleontology
A stem-loop RNA (SLR) RIG-I agonist is effective in preventing and treating acute SARS-CoV-2 infection in mice. A single injection of SLR can clear chronic SARS-CoV-2 in immunocompromised mice. SLR is effective against the ancestral virus as well as variants of concern.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom